An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression versus a single drug, according to a randomized study. Median ...
Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback